📣 Creators, Exciting News!
Gate Square Certified Creator Application Is Now Live!
How to apply:
1️⃣ Open App → Tap [Square] at the bottom → Click your avatar in the top right
2️⃣ Tap [Get Certified] under your avatar
3️⃣ Once approved, you’ll get an exclusive verified badge that highlights your credibility and expertise!
Note: You need to update App to version 7.25.0 or above to apply.
The application channel is now open to KOLs, project teams, media, and business partners!
Super low threshold, just 500 followers + active posting to apply!
At Gate Square, everyone can be a community leader! �
Anglikan: The only innovative drug project currently under research is ALK-N001.
Golden Ten Data on June 9, Anglikang issued a change announcement, the company’s shares for 2 consecutive trading days closing price deviation of more than 20%, belongs to the abnormal fluctuation of stock trading. The company’s current innovative drug project under development is only ALK-N001, which obtained the drug clinical trial approval notice in April 2025 and is still in the phase I clinical trial stage as of the disclosure date of this announcement. The R&D of innovative drugs has the characteristics of long cycle, large investment and high uncertainty, so investors should pay attention to investment risks.